chr22-50733069-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000692848.2(SHANK3):​c.*1757G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.233 in 154,402 control chromosomes in the GnomAD database, including 4,555 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.23 ( 4482 hom., cov: 33)
Exomes 𝑓: 0.24 ( 73 hom. )

Consequence

SHANK3
ENST00000692848.2 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.371

Publications

9 publications found
Variant links:
Genes affected
SHANK3 (HGNC:14294): (SH3 and multiple ankyrin repeat domains 3) This gene is a member of the Shank gene family. Shank proteins are multidomain scaffold proteins of the postsynaptic density that connect neurotransmitter receptors, ion channels, and other membrane proteins to the actin cytoskeleton and G-protein-coupled signaling pathways. Shank proteins also play a role in synapse formation and dendritic spine maturation. Mutations in this gene are a cause of autism spectrum disorder (ASD), which is characterized by impairments in social interaction and communication, and restricted behavioral patterns and interests. Mutations in this gene also cause schizophrenia type 15, and are a major causative factor in the neurological symptoms of 22q13.3 deletion syndrome, which is also known as Phelan-McDermid syndrome. Additional isoforms have been described for this gene but they have not yet been experimentally verified. [provided by RefSeq, Mar 2012]
SHANK3 Gene-Disease associations (from GenCC):
  • Phelan-McDermid syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), ClinGen
  • schizophrenia 15
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.327 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SHANK3NM_001372044.2 linkc.*1757G>A 3_prime_UTR_variant Exon 25 of 25 NP_001358973.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SHANK3ENST00000692848.2 linkc.*1757G>A 3_prime_UTR_variant Exon 23 of 23 ENSP00000510794.2 A0A8I5KZC4

Frequencies

GnomAD3 genomes
AF:
0.233
AC:
35416
AN:
151840
Hom.:
4469
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.332
Gnomad AMI
AF:
0.119
Gnomad AMR
AF:
0.218
Gnomad ASJ
AF:
0.198
Gnomad EAS
AF:
0.203
Gnomad SAS
AF:
0.227
Gnomad FIN
AF:
0.305
Gnomad MID
AF:
0.156
Gnomad NFE
AF:
0.172
Gnomad OTH
AF:
0.231
GnomAD4 exome
AF:
0.236
AC:
578
AN:
2448
Hom.:
73
Cov.:
0
AF XY:
0.245
AC XY:
310
AN XY:
1264
show subpopulations
African (AFR)
AF:
0.265
AC:
18
AN:
68
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
0.500
AC:
1
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
0.291
AC:
25
AN:
86
European-Finnish (FIN)
AF:
0.341
AC:
142
AN:
416
Middle Eastern (MID)
AF:
0.212
AC:
341
AN:
1608
European-Non Finnish (NFE)
AF:
0.156
AC:
15
AN:
96
Other (OTH)
AF:
0.209
AC:
36
AN:
172
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
18
37
55
74
92
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.233
AC:
35465
AN:
151954
Hom.:
4482
Cov.:
33
AF XY:
0.238
AC XY:
17679
AN XY:
74276
show subpopulations
African (AFR)
AF:
0.332
AC:
13762
AN:
41458
American (AMR)
AF:
0.218
AC:
3333
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.198
AC:
686
AN:
3472
East Asian (EAS)
AF:
0.203
AC:
1049
AN:
5178
South Asian (SAS)
AF:
0.227
AC:
1087
AN:
4798
European-Finnish (FIN)
AF:
0.305
AC:
3204
AN:
10504
Middle Eastern (MID)
AF:
0.168
AC:
49
AN:
292
European-Non Finnish (NFE)
AF:
0.172
AC:
11704
AN:
67962
Other (OTH)
AF:
0.229
AC:
483
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1360
2720
4080
5440
6800
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
372
744
1116
1488
1860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.186
Hom.:
4708
Bravo
AF:
0.231

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
0.92
DANN
Benign
0.88
PhyloP100
-0.37
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2301584; hg19: chr22-51171497; COSMIC: COSV53187450; COSMIC: COSV53187450; API